Drug-resistant TB: latest news

Drug-resistant TB resources

  • Multidrug-resistant tuberculosis

    Some strains of tuberculosis have become resistant to some of the standard drugs. These multidrug-resistant (MDR) strains have infected both people with HIV and HIV-negative...

    From: HIV treatments directory

    Information level Level 4
  • Drug-resistant TB

    TB that is resistant to isoniazid and rifampicin, and to other drugs as well, is becoming much more common. This is called multidrug-resistant TB (MDR-TB)...

    From: Booklets

    Information level Level 2

Drug-resistant TB features

Drug-resistant TB news from aidsmap

More news

Drug-resistant TB news selected from other sources

  • New and better drugs for MDR-TB on the horizon

    A phase III trial of a novel combination of drugs for tuberculosis, including some drug-resistant strains, will launch within the year, the TB Alliance announced.

    8 hours ago | The Guardian
  • Big Pharma Abandons New Tuberculosis Drug Research

    Three major pharmaceutical companies - AstraZeneca, Johnson & Johnson and Pfizer - have recently delayed or canceled clinical trials for testing tuberculosis (TB) drugs in India and South Africa. Activists say this is symbolic of a trend by Big Pharma to abandon research into diseases that affect poor people.

    02 April 2014 | CorpWatch.org
  • New consensus reached to help tackle multidrug-resistant and extensively drug-resistant TB

    New consensus statements have been developed to help tackle the growing threat of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.

    26 March 2014 | Eurekalert Medicine & Health
  • Combating Tuberculosis: special report

    Tuberculosis remains one of the greatest public health risks in many low- and middle-income countries, while the emergence of deadly new drug-resistant strains of TB threatens to unravel years of progress.

    24 March 2014 | Financial Times
  • Poor Diagnosis Driving Global Multidrug-Resistant TB, WHO Warns

    In 2012, fewer than 25 percent of the 500,000 people with multidrug-resistant TB (MDR TB) infections received a diagnosis, according to the World Health Organization (WHO). As a result, many MDR TB-infected individuals received the wrong treatment or no treatment at all.

    24 March 2014 | Reuters
  • Tuberculosis cases down by 6% but only 1 in 3 MDR TB patients finishes treatment successfully

    In 2012, 68 423 cases of tuberculosis (TB) were reported in 29 EU/EEA countries according to new data published by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe ahead of World Tuberculosis Day.

    19 March 2014 | ECDC
  • South Africa Battles Drug-Resistant TB

    Despite an increase in diagnosis times, South Africa is facing a growing drug-resistant tuberculosis (TB) burden as nationally there remains a large gap between the number of patients diagnosed with multidrug-resistant TB (MDR-TB) and those who start treatment.

    12 March 2014 | Inter Press Service
  • SIRTURO® (bedaquiline) Receives Conditional Approval in the European Union for the Treatment of Multi-Drug Resistant Tuberculosis

    Janssen-Cilag International NV (Janssen) announced today that the European Commission (EC) has granted conditional approval to SIRTURO® (bedaquiline) in the European Union, for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adult patients, when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

    07 March 2014 | Janssen press release
  • Russia's drug-resistant TB spreading more easily

    Bacterial 'superbugs' are getting ever more potent. Tuberculosis (TB) strains in Russia carry mutations that not only make them resistant to antibiotics but also help them to spread more effectively, according to an analysis of 1,000 genomes from different TB isolates — one of the largest whole-genome study of a single bacterial species so far.

    28 January 2014 | Nature
  • GLOBAL: Xpert MTB/RIF Test Quickly Detects TB and Resistance to Rifampicin

    News-Medical.net reported on a second systematic review of the Xpert® MTB/RIF TB test, which is endorsed by the World Health Organization (WHO). WHO commissioned this updated Cochrane Review as part of the process to update the policy on the use of the test.

    23 January 2014 | CDC National Prevention Information Network
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also